Bank Of Montreal Cytokinetics Inc Transaction History

Bank Of Montreal

$197 Billion
Q2 2024

A detailed history of Bank Of Montreal transactions in Cytokinetics Inc stock. As of the latest transaction made, Bank Of Montreal holds 13,392 shares of CYTK stock, worth $748,612. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,392

Previous 11,665 14.8%

Holding current value

$748,612

Previous $817,000 11.26%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$47.86 - $75.05 $82,654 - $129,611	1,727 Added 14.8%	13,392 $725,000
Q1 2024 May 13, 2024	SELL	$63.75 - $108.06 $28,751 - $48,735	-451 Reduced 3.72%	11,665 $817,000
Q4 2023 Feb 08, 2024	BUY	$26.88 - $83.49 $24,487 - $76,059	911 Added 8.13%	12,116 $1.01 Million
Q3 2023 Nov 01, 2023	SELL	$29.46 - $36.61 $6.87 Million - $8.53 Million	-233,104 Reduced 95.41%	11,205 $330,000
Q2 2023 Aug 02, 2023	BUY	$32.62 - $40.75 $7.65 Million - $9.55 Million	234,452 Added 2378.53%	244,309 $7.97 Million
Q1 2023 Jun 13, 2024	BUY	$33.36 - $45.71 $12.1 Million - $16.6 Million	364,154 Added 3121.77%	375,819 $13.2 Million
Q4 2022 Feb 01, 2023	SELL	$35.77 - $51.11 $17,276 - $24,686	-483 Reduced 4.67%	9,857 $451,000
Q3 2022 Nov 10, 2022	BUY	$38.54 - $54.52 $35,109 - $49,667	911 Added 9.66%	10,340 $556,000
Q2 2022 Aug 11, 2022	SELL	$33.93 - $48.92 $518,518 - $747,595	-15,282 Reduced 61.84%	9,429 $451,000
Q1 2022 May 12, 2022	BUY	$29.74 - $46.0 $13,561 - $20,976	456 Added 1.88%	24,711 $940,000
Q4 2021 Feb 11, 2022	SELL	$34.35 - $46.38 $180,440 - $243,634	-5,253 Reduced 17.8%	24,255 $1.12 Million
Q3 2021 Nov 12, 2021	BUY	$18.54 - $35.74 $58,234 - $112,259	3,141 Added 11.91%	29,508 $1.01 Million
Q2 2021 Aug 12, 2021	BUY	$19.79 - $26.99 $521,802 - $711,645	26,367 New	26,367 $598,000

Others Institutions Holding CYTK

# of Institutions

406

Shares Held

126M

Call Options Held

3.29M

Put Options Held

2.01M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $5.26B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account